Company

Cannara Biotech, Inc.

Headquarters: Montreal, QC, Canada

CEO: Mr. Zohar Krivorot

TSXV: LOVE

Market Cap

C$169.1 Million

CAD as of Jan. 1, 2026

US$123.4 Million

Market Cap History

Cannara Biotech, Inc. Categories

Canada Healthcare Drug Manufacturers—Specialty & Generic
Canada Healthcare Canada Drug Manufacturers—Specialty & Generic

Cannara Biotech, Inc. market capitalization over time

Evolution of Cannara Biotech, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Cannara Biotech, Inc.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector:
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Detailed Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Montreal, Canada.

Stocks & Indices

Cannara Biotech, Inc. has the following listings and related stock indices.


Stock: TSXV: LOVE wb_incandescent

Stock: FSX: 8CB wb_incandescent

Stock: OTC: LOVFF wb_incandescent

Details

Headquarters:

333 Decarie boulevard

Suite 200 St-Laurent

Montreal, QC H4N 3M9

Canada